|
GNAI3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.155900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.140620E-03 |
| Normal-vs-Stage2 |
4.175200E-03 |
| Normal-vs-Stage3 |
7.141800E-03 |
| Normal-vs-Stage4 |
1.016930E-04 |
| Stage1-vs-Stage2 |
6.465000E-01 |
| Stage1-vs-Stage3 |
9.762200E-01 |
| Stage1-vs-Stage4 |
8.234300E-02 |
| Stage2-vs-Stage3 |
7.086600E-01 |
| Stage2-vs-Stage4 |
3.249400E-01 |
| Stage3-vs-Stage4 |
1.408560E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.917300E-03 |
| Normal-vs-AfricanAmerican |
9.370400E-02 |
| Normal-vs-Asian |
1.076400E-03 |
| Caucasian-vs-AfricanAmerican |
6.696400E-01 |
| Caucasian-vs-Asian |
3.993600E-01 |
| AfricanAmerican-vs-Asian |
2.802400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.175120E-03 |
| Normal-vs-Female |
9.758800E-04 |
| Male-vs-Female |
5.258200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.360370E-02 |
| Normal-vs-Age(41-60Yrs) |
1.226580E-04 |
| Normal-vs-Age(61-80Yrs) |
1.282720E-03 |
| Normal-vs-Age(81-100Yrs) |
3.923800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.234200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.649820E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.710800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.671600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.765000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.453800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.725600E-01 |
| Classical-VS-Follicular |
9.698100E-03 |
| Classical-VS-Other |
3.396200E-01 |
| Classical-VS-Normal |
4.519500E-03 |
| Tall-VS-Follicular |
8.489700E-02 |
| Tall-VS-Other |
4.106800E-01 |
| Tall-VS-Normal |
2.754200E-01 |
| Follicular-VS-Other |
9.473000E-01 |
| Follicular-VS-Normal |
9.78419999999591E-05 |
| Other-VS-Normal |
5.251800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.385210E-04 |
| Normal-vs-N1 |
1.211640E-04 |
| N0-vs-N1 |
2.908200E-01 |
|
|
